Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
An average 4 cm height gain... 1.57 inches (1) from an injectable
therapy with unknown later risks to health (2) and questionable benefit to
the individual (3).
By my calculations the cost of growth hormone for that 4cm for a
single child would provide 200,000 doses of measles vaccine or 28 village
pumps for sub-Saharan Africa. Shouldn't global ethics be considered?
1) Deodati A, Cianfarani S. Impact of growth hormone therapy on adult
height of children with idiopathic short stature: systematic review. BMJ
2) J. Bell, K. L. Parker, R. D. Swinford, A. R. Hoffman, T. Maneatis
and B. Lippe. Long-Term Safety of Recombinant Human Growth Hormone in
Children. The Journal of Clinical Endocrinology & Metabolism 2010;
3) Sandberg DE. The psychosocial consequences of short stature: a
review of the evidence. Best Practice & Research Clinical
Endocrinology & Metabolism 2002;16: 449-463 .
Dr Wales prescribes Growth Hormone from all current UK manufacturers for current licensed indications detailed in the BNF for Children.